Swiss National Bank - PLIANT THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Swiss National Bank ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,579,674
-9.4%
91,100
-5.3%
0.00%0.0%
Q2 2023$1,743,144
-29.2%
96,200
+4.0%
0.00%
-50.0%
Q1 2023$2,460,500
+44.5%
92,500
+5.0%
0.00%
+100.0%
Q4 2022$1,702,973
+714.8%
88,100
+195.6%
0.00%
Q1 2022$209,000
-43.5%
29,800
+8.8%
0.00%
Q4 2021$370,000
-20.1%
27,4000.0%0.00%
Q3 2021$463,000
-42.0%
27,4000.0%0.00%
Q2 2021$798,000
-15.5%
27,400
+14.2%
0.00%
-100.0%
Q1 2021$944,000
+73.2%
24,0000.0%0.00%
Q4 2020$545,00024,0000.00%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 5,839,160$98,565,00018.71%
CHI Advisors LLC 2,484,724$41,942,00012.24%
TRV GP IV, LLC 2,132,867$36,003,0008.17%
Bond & Devick Financial Network, Inc. 120,160$2,028,0001.68%
Fernwood Investment Management, LLC 166,447$2,810,0000.96%
Redmile Group, LLC 3,083,501$52,049,0000.91%
HARVARD MANAGEMENT CO INC 562,379$9,493,0000.56%
Grace Capital 48,058$808,0000.50%
Eventide Asset Management 2,183,238$36,853,0000.49%
Cormorant Asset Management, LP 482,413$8,143,0000.33%
View complete list of PLIANT THERAPEUTICS INC shareholders